title: Managed care approach to the treatment of neurogenic orthostatic hypotension.
abstract: Neurogenic orthostatic hypotension (NOH) is an orphan disease that primarily affects patients with neurodegenerative disorders such as Parkinson's disease and multiple system atrophy. The first step in the management of NOH is to discontinue or minimize the use of drugs that lower blood pressure. Nonpharmacologic therapy for NOH includes physical countermaneuvers, compression abdominal binders and lower extremity stockings, recognition and avoidance of orthostatic stressors, hydration, and salt supplementation. The management of NOH should also include interventions to prevent falls. Pharmacotherapy for NOH includes the mineralocorticoid drug fludrocortisone to expand plasma volume and the sympathomimetic drugs midodrine and droxidopa. Clinical efficacy, tolerability, and the role of each drug in the treatment paradigm are reviewed here.
authors.affiliation: isaacson@ParkinsonsCenter.org.
authors.forename: Stuart H
authors.initials: SH
authors.lastname: Isaacson
mesh_terms: D000058:Accidental Falls / Q000517:prevention & control; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*; D019636:Neurodegenerative Diseases / Q000503:physiopathology*; D010353:Patient Education as Topic; D011788:Quality of Life; D013566:Sympathomimetics / Q000627:therapeutic use*; D013575:Syncope / Q000517:prevention & control
chemical_list: D013566:Sympathomimetics